Exagen Affirms FY2026 Sales Guidance of $72.000M-$75.000M vs $73.886M Est
Benzinga Newsdesk 2 hours ago
NewsGuidance
Exagen (NASDAQ:XGN) affirms FY2026 sales outlook from $72.000 million-$75.000 million to $72.000 million-$75.000 million vs $73.886 million estimate.
Exagen (NASDAQ:XGN) affirms FY2026 sales outlook from $72.000 million-$75.000 million to $72.000 million-$75.000 million vs $73.886 million estimate.